triamcinolone acetonide has been researched along with B16 Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Djordjević-Marković, R; Kanazir, DT; Radojcić, M; Ribarac-Stepić, N; Ristić-Fira, A | 1 |
Kanazir, D; Krstic-Demonacos, M; Ristic-Fira, A; Vujcic, M | 1 |
Lindemeyer, RG; Litwack, G; Robertson, NM | 1 |
3 other study(ies) available for triamcinolone acetonide and B16 Melanoma
Article | Year |
---|---|
Glucocorticoid receptors in mouse melanoma cells.
Topics: Animals; Cell Division; Cortodoxone; Melanoma, Experimental; Mice; Receptors, Glucocorticoid; Triamcinolone Acetonide; Tumor Cells, Cultured | 1995 |
Identification and characterization of glucocorticoid receptors in B16 mouse melanoma cells.
Topics: Animals; Antibodies, Monoclonal; Binding Sites; Cell Division; Chromatography, Ion Exchange; Glucocorticoids; Melanoma, Experimental; Mice; Receptors, Glucocorticoid; Triamcinolone Acetonide; Tumor Cells, Cultured | 1999 |
Glucocorticoid receptor monoclonal antibodies define the biological action of RU 38486 in intact B16 melanoma cells.
Topics: Animals; Antibodies, Monoclonal; Cell Line; Cell Nucleus; Cortodoxone; Fluorescent Antibody Technique; Immunoglobulin M; Melanoma, Experimental; Mice; Mifepristone; Receptors, Glucocorticoid; Triamcinolone Acetonide | 1990 |